Comparative metabologenomics analysis of polar actinomycetes

Soldatou, S., Eldjárn, G. H., Ramsay, A. , Van Der Hooft, J. J.J. , Hughes, A. H., Rogers, S. and Duncan, K. R. (2021) Comparative metabologenomics analysis of polar actinomycetes. Marine Drugs, 19(2), 103. (doi: 10.3390/md19020103) (PMID:33578887) (PMCID:PMC7916644)

[img] Text
233947.pdf - Published Version
Available under License Creative Commons Attribution.

2MB

Publisher's URL: https://www.mdpi.com/1660-3397/19/2/103

Abstract

Biosynthetic and chemical datasets are the two major pillars for microbial drug discovery in the omics era. Despite the advancement of analysis tools and platforms for multi-strain metabolomics and genomics, linking these information sources remains a considerable bottleneck in strain prioritisation and natural product discovery. In this study, molecular networking of the 100 metabolite extracts derived from applying the OSMAC approach to 25 Polar bacterial strains, showed growth media specificity and potential chemical novelty was suggested. Moreover, the metabolite extracts were screened for antibacterial activity and promising selective bioactivity against drug-persistent pathogens such as Klebsiella pneumoniae and Acinetobacter baumannii was observed. Genome sequencing data were combined with metabolomics experiments in the recently developed computational approach, NPLinker, which was used to link BGC and molecular features to prioritise strains for further investigation based on biosynthetic and chemical information. Herein, we putatively identified the known metabolites ectoine and chrloramphenicol which, through NPLinker, were linked to their associated BGCs. The metabologenomics approach followed in this study can potentially be applied to any large microbial datasets for accelerating the discovery of new (bioactive) specialised metabolites.

Item Type:Articles
Additional Information:This research was funded by Carnegie Trust Collaborative Research Grant (KRD, SR, SS). AR, KRD and SR were supported by the Biotechnology and Biological Sciences Research Council (BB/R022054/1). Additionally, genome sequencing was provided by MicrobesNG (http://www.microbesng.uk) which was supported by the Biotechnology and Biological Sciences Research Council (BB/L024209/1).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Rogers, Dr Simon and Van Der Hooft, Mr Justin and Ramsay, Mr Andrew
Creator Roles:
Ramsay, A.Writing – review and editing
Van Der Hooft, J. J.J.Writing – review and editing
Rogers, S.Conceptualization, Methodology, Formal analysis, Investigation, Writing – original draft, Writing – review and editing, Supervision, Project administration, Funding acquisition
Authors: Soldatou, S., Eldjárn, G. H., Ramsay, A., Van Der Hooft, J. J.J., Hughes, A. H., Rogers, S., and Duncan, K. R.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
College of Science and Engineering > School of Computing Science
Journal Name:Marine Drugs
Publisher:MDPI
ISSN:1660-3397
ISSN (Online):1660-3397
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Marine Drugs 19(2):103
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
302697Combatting antimicrobial resistance through new software for natural product discoverySimon RogersBiotechnology and Biological Sciences Research Council (BBSRC)BB/R022054/1Computing Science